CIK 0001631574 · Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Tan Aik Na Director | Grant or award | +25,400 | 40,388 | ||
| 2025-08-11 | Tan Aik Na Director | Grant or award · Share Option (right to buy) | +152,400 | 152,400 | ||
| 2025-08-11 | TAKANASHI KEN Director | Grant or award | +12,700 | 5,729,003 | ||
| 2025-08-11 | TAKANASHI KEN Director | Grant or award · Share Option (right to buy) | +76,200 | 76,200 | ||
| 2025-08-11 | Wagner Heidi L Director | Grant or award | +12,700 | 44,930 | ||
| 2025-08-11 | Wagner Heidi L Director | Grant or award · Share Option (right to buy) | +76,200 | 76,200 | ||
| 2025-08-11 | HENRY CHRISTIAN O Director | Grant or award 10b5-1 | +12,700 | 39,315 | ||
| 2025-08-11 | HENRY CHRISTIAN O Director | Grant or award · Share Option (right to buy) 10b5-1 | +76,200 | 76,200 | ||
| 2025-08-11 | Rawcliffe Adrian Director | Grant or award | +12,700 | 28,815 | ||
| 2025-08-11 | Rawcliffe Adrian Director | Grant or award · Share Option (right to buy) | +76,200 | 76,200 | ||
| 2025-08-11 | Verdine Gregory L. Director | Grant or award | +12,700 | 295,217 | ||
| 2025-08-11 | Verdine Gregory L. Director | Grant or award · Share Option (right to buy) | +76,200 | 76,200 | ||
| 2025-08-05 | TAKANASHI KEN Director | Sale 10b5-1 | −4,872 | $8.75 | $43K | 5,716,303 |
| 2025-08-05 | Tan Aik Na Director | Sale 10b5-1 | −1,127 | $8.75 | $10K | 14,988 |
| 2025-06-13 | Verdine Gregory L. Director | Sale 10b5-1 | −30,000 | $6.95 | $209K | 282,517 |
| 2025-03-20 | HENRY CHRISTIAN O Director | Option exercise 10b5-1 | +10,500 | $9.13 | $96K | 26,615 |
| 2025-03-20 | HENRY CHRISTIAN O Director | Sale 10b5-1 | −10,500 | $9.77 | $103K | 16,115 |
| 2025-03-20 | HENRY CHRISTIAN O Director | Option exercise · Share Option (right to buy) 10b5-1 | −10,500 | 0 | ||
| 2025-03-07 | BOLNO PAUL President and CEO | Option exercise 10b5-1 | +169,025 | $2.48 | $419K | 507,376 |
| 2025-03-07 | BOLNO PAUL President and CEO | Sale 10b5-1 | −169,025 | $9.57 | $1.6M | 338,351 |
Page 8 of 13 · 255 trades